Skip to main content
. 2022 Sep 30;7(12):2639–2646. doi: 10.1016/j.ekir.2022.09.030

Table 4.

Follow-ups on complications and outcome of PD

Patient # 1 2 3 4 5 6 7 8
PD modality CAPD CAPD→APD CAPD CAPD CAPD CAPD CAPD CAPD
Outcome Continue Continue Continue Transferred Deceased Continue Continue Continue
Total follow-ups (mo) 159 131 86 7 13 17 21 6
6-month average F VIII infusion before PD Data unavailable Data unavailable 0 0 NAa 108 IU/d 94 IU/d NAa
6-month average F VIII infusion after PD 33 IU/d 68 IU/d 0 0 NAa 266 IU/d 301 IU/d NAa
Days per hemorrhage episode 1 year before PD Data unavailable Data unavailable NAb NAb NAc 127 77 NAc
Days per hemorrhage after PDd 167 165 2395 NAb NAc 76 90 NAc
Hemoperitoneum after PD 0 2 1 0 0 0 2 Data unavailable
6-month average Hgb before PD (g/l) 105 78 81 85 78 94 89 67
6-month average Hgb after PD (g/l)e 111 111 147 112 112.5 118 78 112
Average peritonitis rates (mo) 159 33 17 7 13 17 21 Data unavailable
Average peritonitis rates of corresponding controlf (mo) 77 56 71 69 68 69 69 68
Tunnel exit infection (counts) 4 4 4 1 3 0 2 0
Most recent CCr l/w 1.73 m2 62.4 52.01 37.5 97.3 51.2 94.1 61.8 76.6
Most recent KT/V 1.93 1.77 1.50 2.14 1.61 2.71 1.65 1.97
Most recent nPCR g/kd.d 0.90 0.57 0.93 0.83 0.64 0.95 0.78 0.95
Most recent rGFR ml/min 0 0 0 5.85 1.63 6.18 0.78 3.05
Most recent UF (ml/d) 900 1200 2400 500 1050 180 450 −200
Most recent Urine (ml/d) 0 0 0 1250 550 1350 350 1500

APD, automated peritoneal dialysis; CAPD, continuous ambulatory peritoneal dialysis; F VIII, coagulation factor III; Hgb, hemoglobin; PD, peritoneal dialysis; UF, ultrafiltration.

a

Acquired HA.

b

No significant hemorrhage event was noticed in the previous year.

c

Incomparable due to improvement in F VIII inhibitors.

d

One year or longest possible follow-up duration, whichever shorter.

e

Or longest possible follow-up duration, whichever shorter.

f

Compared to patients of the same age group in general male PD patients.